Literature DB >> 29672888

Fibroblast Growth Factor 15-Dependent and Bile Acid-Independent Promotion of Liver Regeneration in Mice.

Bo Kong1,2, Runbin Sun3, Mingxing Huang4, Monica D Chow5, Xiao-Bo Zhong6, Wen Xie7, Yi-Horng Lee8, Grace L Guo2,9.   

Abstract

The role of intestine-derived factors in promoting liver regeneration after partial hepatectomy (PHx) are not entirely known, but bile acids (BAs) and fibroblast growth factor 15 (Fgf15) that is highly expressed in the mouse ileum could promote hepatocyte proliferation. Fgf15 strongly suppresses the synthesis of BAs, and emerging evidence indicates that Fgf15 is important for liver regeneration. The mechanisms by which Fgf15 promotes liver regeneration are unclear, but Fgf15 may do so indirectly by reducing BA levels and/or directly by promoting cell proliferation. However, it remains undetermined whether these two mechanisms are independent or integrated. In this study, we aimed to clarify these relationships by generating Fgf15 Tet-Off, transgenic mice (Fgf15 Tg) that had very low BA levels as a result from overexpressed Fgf15-mediated suppression of BA synthesis. Compared with wild-type mice, the Fgf15 Tg mice showed increased hepatocyte proliferation even without surgery, and a further induction of the genes in cell-cycle progression after PHx. Moreover, overexpression of Fgf15 by adeno-associated virus (AAV)-Fgf15 transduction or treatment with the recombinant Fgf15 protein led to increased cell proliferation in vivo. Furthermore, Fgf15 Tg mice exhibited an earlier and greater activation of mitogen-activated protein kinase, signal transducer and activator of transcription 3, and NF-κB signaling pathways in the priming stage, and a disruption of the hippo signaling pathway in the termination stage of liver regeneration.
Conclusion: Direct in vivo evidence demonstrates that Fgf15 is critical in stimulating the phases of priming and termination of liver regeneration that are critical for cell survival and liver-size determination, independent of BA levels. (Hepatology 2018; 00:000-000).
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29672888      PMCID: PMC6195490          DOI: 10.1002/hep.30041

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

1.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.

Authors:  Y Yamada; I Kirillova; J J Peschon; N Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 2.  The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.

Authors:  Xaralabos Varelas
Journal:  Development       Date:  2014-04       Impact factor: 6.868

3.  External biliary drainage and liver regeneration after major hepatectomy.

Authors:  R Otao; T Beppu; T Isiko; K Mima; H Okabe; H Hayashi; T Masuda; A Chikamoto; H Takamori; H Baba
Journal:  Br J Surg       Date:  2012-11       Impact factor: 6.939

Review 4.  Fibroblast growth factors: key players in regeneration and tissue repair.

Authors:  Luigi Maddaluno; Corinne Urwyler; Sabine Werner
Journal:  Development       Date:  2017-11-15       Impact factor: 6.868

Review 5.  Hippo signaling in organ size control.

Authors:  Duojia Pan
Journal:  Genes Dev       Date:  2007-04-15       Impact factor: 11.361

6.  Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice.

Authors:  Iker Uriarte; Maite G Fernandez-Barrena; Maria J Monte; Maria U Latasa; Haisul C Y Chang; Simone Carotti; Umberto Vespasiani-Gentilucci; Sergio Morini; Eva Vicente; Axel R Concepcion; Juan F Medina; José Juan G Marin; Carmen Berasain; Jesus Prieto; Matías A Avila
Journal:  Gut       Date:  2013-01-03       Impact factor: 23.059

7.  Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice.

Authors:  Insook Kim; Keiichirou Morimura; Yatrik Shah; Qian Yang; Jerrold M Ward; Frank J Gonzalez
Journal:  Carcinogenesis       Date:  2006-12-20       Impact factor: 4.944

Review 8.  Bile acid metabolism and signaling.

Authors:  John Y L Chiang
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

9.  The receptor tyrosine kinase FGFR4 negatively regulates NF-kappaB signaling.

Authors:  Kristine A Drafahl; Christopher W McAndrew; April N Meyer; Martin Haas; Daniel J Donoghue
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

10.  Bile acid flux is necessary for normal liver regeneration.

Authors:  Willscott E Naugler
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

View more
  11 in total

1.  Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis Development.

Authors:  Justin D Schumacher; Bo Kong; Jason Wu; Daniel Rizzolo; Laura E Armstrong; Monica D Chow; Michael Goedken; Yi-Horng Lee; Grace L Guo
Journal:  Hepatology       Date:  2019-08-09       Impact factor: 17.425

2.  mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy.

Authors:  Meng Xu; Haichuan Wang; Jingxiao Wang; Deviana Burhan; Runze Shang; Pan Wang; Yi Zhou; Rong Li; Bingyong Liang; Katja Evert; Kirsten Utpatel; Zhong Xu; Xinhua Song; Li Che; Diego F Calvisi; Bruce Wang; Xi Chen; Yong Zeng; Xin Chen
Journal:  Am J Pathol       Date:  2020-02-05       Impact factor: 4.307

Review 3.  Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis.

Authors:  Yong-Yu Yang; Li Xie; Ning-Ping Zhang; Da Zhou; Tao-Tao Liu; Jian Wu
Journal:  Acta Pharmacol Sin       Date:  2022-02-21       Impact factor: 7.169

Review 4.  The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.

Authors:  Lulu Sun; Jie Cai; Frank J Gonzalez
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-10       Impact factor: 46.802

Review 5.  Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gabriella Garruti; Mirco Vacca; Maria De Angelis; David Q-H Wang
Journal:  Nutrients       Date:  2020-11-30       Impact factor: 5.717

Review 6.  FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human.

Authors:  Emma Henriksson; Birgitte Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-22       Impact factor: 5.555

7.  Gelatine nanostructured lipid carrier encapsulated FGF15 inhibits autophagy and improves recovery in spinal cord injury.

Authors:  Yibo Ying; Guangheng Xiang; Min Chen; Jiahui Ye; Qiuji Wu; Haicheng Dou; Sunren Sheng; Sipin Zhu
Journal:  Cell Death Discov       Date:  2020-12-02

Review 8.  Molecular pathways of liver regeneration: A comprehensive review.

Authors:  Yana V Kiseleva; Sevak Z Antonyan; Tatyana S Zharikova; Kirill A Tupikin; Dmitry V Kalinin; Yuri O Zharikov
Journal:  World J Hepatol       Date:  2021-03-27

9.  Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein.

Authors:  Martin J Ronis; Kelly E Mercer; Kartik Shankar; Casey Pulliam; Kim Pedersen; Magnus Ingelman-Sundberg; Simonetta Friso; Derrick Samuelson; Luis Del Valle; Chris Taylor; David A Welsh
Journal:  Chem Biol Interact       Date:  2020-05-14       Impact factor: 5.192

10.  Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency.

Authors:  Mingxing Huang; Bo Kong; Min Zhang; Daniel Rizzolo; Laura E Armstrong; Justin D Schumacher; Monica D Chow; Yi-Horng Lee; Laurie B Joseph; Mary Stofan; Lanjing Zhang; Grace L Guo
Journal:  Lab Invest       Date:  2020-05-13       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.